Omics integration

  • Integration: Integrating LC-MS-based proteomics with other techniques such as genomics and transcriptomics allows for a detailed and comprehensive understanding of biological system. Such holistic approaches, which enhance the robustness and impact of findings, lead to projects with higher outcomes.
  • Biomarkers: Proteomics is the method of choice for identifying biomarkers, which are crucial for understanding biological systems. Biomarker identification contributes to understanding disease mechanisms and progression, as well as developing personalized treatment approaches that enhance patient outcomes and advance biomedical and clinical research
  • Drug Discovery: LC-MS-based biomarker identification is essential in drug discovery, helping to identify potential therapeutic targets and evaluate drug efficacy in biological, biomedical, and clinical research, across in vitro, in vivo, and ex vivo experiments.